Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-03-01 @ 1:45 PM
Study NCT ID:
NCT04465734
Status:
WITHDRAWN
Last Update Posted:
2022-05-05
First Post:
2020-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-10-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03-15
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-07
First Submit QC Date:
None
Study First Post Date:
2020-07-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-01
Last Update Post Date:
2022-05-05
Last Update Post Date Type:
ACTUAL